Magnesium hydrogen carbonate natural mineral water enriched with K+-citrate and vitamin B6 improves urinary abnormalities in patients with calcium oxalate nephrolithiasis

Urologia Internationalis

Volumn 60, Issue 2, 1998, Pages 105-107

  Bren, Andrej ^a   Kmetec, Andrej ^a   Kveder, Rado ^a   Kaplan Pavlovčič, Staša ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Calcium oxalate nephrolithiasis; Natural mineral water; Urinary abnormalities

Indexed keywords

BICARBONATE; CALCIUM; CALCIUM OXALATE; CITRATE POTASSIUM; CITRIC ACID; CREATININE; MAGNESIUM; MINERAL WATER; PYRIDOXINE;

ADULT; ARTICLE; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAGNESIUM URINE LEVEL; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; URINALYSIS; URINE COMPOSITION DISORDER; URINE PH;

ADULT; CALCIUM OXALATE; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNESIUM; MALE; MIDDLE AGED; MINERAL WATERS; POTASSIUM CITRATE; PROSPECTIVE STUDIES; PYRIDOXINE; RECURRENCE; TREATMENT OUTCOME; URINARY CALCULI; URINATION DISORDERS;

EID: 0031914220     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030221     Document Type: Article

References (20)

1. Pak CYC: General guidelines in management: in Resnick MI, Pak CYC (eds): Urolithiasis A Medical and Surgical Reference. Philadelphia, Saunders, 1990, pp 173-184.
2. Hesse A, Classen A, Knoll M, Timmermann F, Vahlensieck W: Dependence of urine composition on the age and sex of healthy subjects. Clin Chem Acta 1986;160:79-86.
3. Pearle MS, Pak CYC: Renal calculi: A practical approach to medical evaluation and management; in Andreucci VE, Fine LG (eds): International Yearbook of Nephrology. New York. Oxford University Press, 1996, pp 69-80.
4. Marshall VR: Stone formation, pathogenesis, composition of stone, medical treatment. Curr Opin Urol 1992;2:306-309.
5. Pak CYC: Citrate and renal calculi: New insights and future directions. Am J Kidney Dis 1991;17:420-425.
6. Hallson PC, Rose GA, Sulaiman S: Magnesium reduces calcium oxalate crystal formation in human whole urine. Clin Sci 1982;62:17-19.
7. Li MK, Blacklock NJ, Garside J: Effects of magnesium on calcium oxalate crystallization. J Urol 1985;133:123-125.
8. Khan SR, Shevock PN, Hacket RL: Magnesium oxide administration and prevention of calcium oxalate nephrohthiasis. J Urol 1993;149:412-416.
9. Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, Wolfe H, Dale R, Daley M, Malik I, Schnarch S: Soft drink consumption and urinary stone recurrence: A randomized prevention trial. J Clin Epidemiol 1992;45:911-916.
10. Cowley DM, Whinney BC, Brown JM, Chalmers AH: Effect of citrate on the urinary excretion of calcium and oxalate: Relevance to calcium oxalate nephrolithiasis. Clin Chem 1989;35:23-28.
11. Berg C, Larson L, Tiselius HG: The effects of single evening dose of alkaline citrate on urine composition and calcium stone formation. J Urol 1992;148:979-985.
12. Robertson WG: Aethiological factors in stone formation; in Cameron S, Davison AM, Grünfeld JP, Kerr D, Ritz E (eds): Oxford Textbook of Clinical Nephrology. Oxford, Oxford University Press, 1992, pp 1822-1846.
13. Barcelo P, Wuhl O, Servitge R, Rousaud A, Pak CYC: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993;150:1761-1764.
14. Asplin JR, Favus MJ, Coe FL: Nephrolithiasis; in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 1996, pp 1893-1935.
15. Koenig K, Padalino P, Alexandrides G, Pak CYC: Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate. J Urol 1991;145:330-334.
16. Muldowney FP, Freaney R, Moloney MF: Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982;22:292-296.
17. Leman J Jr Nephrohthiasis; in Massry SG, Glassock RJ (eds): Textbook of Nephrology. Baltimore, Williams & Wilkms, 1984, pp 6.266-6.282.
18. Goldfarb S: Dietary factors in the pathogenesis and prophylaxis of calcium nephrolithiasis. Kidney Int 1988;34:544-555.
19. Ettinger B, Citron JT, Livermore B, Dolman LI: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 1988;139:679-684.
20. Ryall RL: Metabolic aspects of stone disease: Graven images and pipe dreams. Curr Opin Urol 1994;4 223-228.